1. Home
  2. VNDA vs LMNR Comparison

VNDA vs LMNR Comparison

Compare VNDA & LMNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • LMNR
  • Stock Information
  • Founded
  • VNDA 2002
  • LMNR 1893
  • Country
  • VNDA United States
  • LMNR United States
  • Employees
  • VNDA N/A
  • LMNR N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • LMNR Farming/Seeds/Milling
  • Sector
  • VNDA Health Care
  • LMNR Consumer Staples
  • Exchange
  • VNDA Nasdaq
  • LMNR Nasdaq
  • Market Cap
  • VNDA 261.7M
  • LMNR 292.4M
  • IPO Year
  • VNDA 2006
  • LMNR N/A
  • Fundamental
  • Price
  • VNDA $4.55
  • LMNR $15.00
  • Analyst Decision
  • VNDA Strong Buy
  • LMNR Strong Buy
  • Analyst Count
  • VNDA 3
  • LMNR 1
  • Target Price
  • VNDA $15.33
  • LMNR $23.00
  • AVG Volume (30 Days)
  • VNDA 362.5K
  • LMNR 77.3K
  • Earning Date
  • VNDA 07-30-2025
  • LMNR 06-09-2025
  • Dividend Yield
  • VNDA N/A
  • LMNR 2.02%
  • EPS Growth
  • VNDA N/A
  • LMNR N/A
  • EPS
  • VNDA N/A
  • LMNR N/A
  • Revenue
  • VNDA $201,351,000.00
  • LMNR $176,590,000.00
  • Revenue This Year
  • VNDA $16.86
  • LMNR N/A
  • Revenue Next Year
  • VNDA $39.78
  • LMNR N/A
  • P/E Ratio
  • VNDA N/A
  • LMNR N/A
  • Revenue Growth
  • VNDA 13.37
  • LMNR N/A
  • 52 Week Low
  • VNDA $3.81
  • LMNR $14.64
  • 52 Week High
  • VNDA $6.37
  • LMNR $29.22
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 53.76
  • LMNR 40.24
  • Support Level
  • VNDA $4.49
  • LMNR $14.64
  • Resistance Level
  • VNDA $4.63
  • LMNR $17.19
  • Average True Range (ATR)
  • VNDA 0.14
  • LMNR 0.66
  • MACD
  • VNDA 0.00
  • LMNR -0.08
  • Stochastic Oscillator
  • VNDA 50.00
  • LMNR 9.02

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

Share on Social Networks: